Table 3 Correlations of mean CD31 and D2-40 microvessel density, visually and image cytometrically, with clinicopathologic parameters of breast carcinoma (expressed as Pearson's correlations with associated P-values)

From: Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression

Clinicopathologic parameter

Microvessel density technique

 

CD31

(visual)

D2-40

(visual)

CD31

(image cytometric)

D2-40

(image cytometric)

Patient age

−0.0878

(P=0.6507)

−0.3074

(P=0.1048)

0.1062

(P=0.5907)

−0.3553

(P=0.0635)

Tumor size

0.2998

(P=0.1141)

0.1213

(P=0.5308)

0.6669

(P =0.0001)

0.0879

(P=0.6567)

Histologic type

−0.0039

(P=9841)

−0.1418

(P=0.4633)

0.1255

(P=0.5247)

−0.0501

(P=0.8001)

Histologic grade

−0.0912

(P=0.6382)

0.0360

(P=0.8531)

0.4746

(P =0.0107)

−0.0077

(P=0.9690)

Lymph node status

−0.1840

(P=0.3393)

0.3590

(P =0.0558)

0.3912

(P =0.0395)

0.1713

(P=0.3835)

Tumor stage

0.3529

(P=0.0604)

0.2632

(P=0.1677)

0.5324

(P =0.0035)

0.4669

(P =0.0123)

Estrogen receptor status

−0.2516

(P=0.1880)

−0.0435

(P=0.8227)

−0.3425

(P=0.0744)

0.0442

(P=0.8230)

Progesterone receptor status

−0.1886

(P=0.3272)

0.0650

(P=0.7378)

−0.0553

(P=0.7799)

0.3430

(P=0.0739)

HER2/neu status

0.1576

(P=0.4141)

−0.1660

(P=0.3894)

−0.0260

(P=0.8957)

0.0152

(P=0.9389)

  1. Significant correlations are in boldface.